Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Pathophysiology, Mechanism, Diagnosis and Management of PAH
Author(s): Apoorva Gangavelli , Ronaldo C Fabiano , Mariam Riad , et al Added: 1 month ago

Prevention & Chronic Conditions
AHA 23: KABUKI: DOAC in Pts with CTEPH
Author(s): Kazuya Hosokawa , Abe Kotaro Added: 2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3… View more

Prevention & Chronic Conditions
Left Atrial Myxoma
Author(s): Preet Shaikh , Mario Rodriguez Rivera , Michael A Beal , et al Added: 1 year ago

Heart Failure

Prevention & Chronic Conditions
Job title: Director of the National Pulmonary Hypertension Service
Job title: Head of the Paediatric Cardiology Unit
Shao-Liang Chen
Research Area(s) / Expertise:
Dr Shao-Liang Chen is an interventional cardiologist at theNanjing First Hospital, Nanjing Medical University, Jiangsu Province, Nanjing, China. Dr Chen has published over 300 papers in peer-reviewed journals. Dr Chen's research interests include coronary intervention, pulmonary arterial hypertension and biological molecular science. Dr Shao-Liang Chen is Section Editor of European… View more
Research Area(s) / Expertise: Job title: Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program
Myung H Park, MD, FACC, is an Assistant Professor of Medicine in the Division of Cardiology and Director of the Pulmonary Vascular Diseases Program at the University of Maryland School of Medicine. She is a member of the American College of Cardiology, the Heart Failure Society of America, the International Society of Heart and Lung Transplantation, and the Pulmonary Hypertension Association… View more
ACC 25 Late-Breaking Discussion: The ADVANCE-HTN Trial
Author(s): Harriette Van Spall , Luke Laffin Added: 11 months ago
ACC 25 - ADVANCE-HTN shows lorundrostat, an aldosterone synthase inhibitor, effectively lowered 24-hour blood pressure in patients with uncontrolled and true resistant hypertension.Late-breaker discussion host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Dr Luke Laffin (Cleveland Clinic, Cleveland, OH, US) to discuss the key findings from the ADVANCE-HTN trial… View more

Prevention & Chronic Conditions
Shih-Hsien Sung
Dr Adam Sung (Dr Shih-Hsien Sung) received his MD and PhD degrees fromNational Yang-Ming University, Taiwan,in 2001 and 2014, respectively. He has been on the faculty of National Yang Ming Chiao Tung University since 2019, where he is currently a professor. He completed internal medicine residency training and cardiology fellowship training at Taipei Veterans General Hospital in 2009, where he is… View more
Looking Beyond the Usual Suspects: A Rare Case of Stiff Left Atrial Syndrome after Radiotherapy for Breast Cancer
Author(s): Sukriti Banthiya , Medhat Chowdhury , Harshil Patel , et al Added: 2 years ago

CV Disease in Special Populations